Articles by Rachel Flehinger

MANF Therapeutics restarts IND-enabling work in light of new results

Melinta Therapeutics seeks to move investigational pyrrolocytosine compounds into clinical stage

Insilico and WuXi AppTec use AI in drug discovery

A pair of new deals with Daiichi and Takeda help move Thermo’s technology forward

Sutro Biopharma advances STRO-001 and STRO-002 into the clinic against multiple cancer types

Scripps scientists use 3D spheroids to better test cancer drugs’ efficacy

Combination of immune agonists may fight one of the fastest-moving and deadliest of cancers

QIAGEN acquires molecular diagnostics company STAT-Dx and its multiplex technologies

Noncoding mutations found to be a major mechanism in cancer

With half of CAR-T studies in China, Cesca looks to capitalize on market potential with CDMO expansion

CD133 revealed as a potential target for encouraging kidney repair

Merger marries cutting-edge research players

ANGLE and Abbott seek blood test for metastatic breast cancer

New methods emerge to manufacture therapeutic proteins

Kinase inhibitor may prove useful in treating rare genetic disease